Ghida Harfouche has over 19 years of experience across the investment, pharmaceutical and healthcare sectors, coupled with a strong consulting expertise.
Her responsibilities include sourcing, evaluating and executing on new investment opportunities, performing financial and operational due diligence, fund reporting, as well as being actively involved in fundraising activities. She also actively participates in portfolio management, including the strategic expansion planning for portfolio and affiliated companies as well as developing exit strategies and working on exit readiness.
In a previous tenure, Ghida was a Senior Strategy Consultant at Stem-Pharma. Her role encompassed formulating effective market entry strategies, conducting feasibility and M&A analyses, leading the client relationship across Europe, and providing investment advisory services to a variety of regional and European clients.
In addition to her experience in life science consulting, Ghida has a rich scientific research background focused on pioneering novel target identification. She worked in R&D and clinical research at ‘Institut National de la Santé et de la Recherche Médicale’ (INSERM) and ‘Commissariat à l’Energie Atomique’ (CEA) in France. She received several awards during international scientific conferences. Her research findings have been published in a number of international peer-reviewed journals and she has developed a patent in oncology and photo-protection.
Ghida earned a distinguished PhD in Pharmacology, Cell and Molecular Biology from the University of Paris-Sud XI, France. Complementing her scientific acumen, she holds an MBA from Ecole Supérieure des Affaires, Lebanon, and a DESM (Diplôme d’Etudes Supérieures en Management) from ESCP-Europe, France.